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Abstract 
 Fear of blood, injections, and needles commonly prevents or delays individuals’ receipt 
of health care, such as vaccines or blood draws. Innovative methods are needed to overcome 
these fears and reduce anxiety related to activities of this nature. The present study describes 
initial testing of an arm illusion paradigm that may prove useful during early phases of graded 
exposure for people with blood and needle fear. Seventy-four undergraduate students aged 18-29 
years were tested. In line with study aims, results indicated that the virtual blood draw paradigm 
promoted strong perceptions of arm ownership and elicited significant changes in physiological 
indices (blood pressure, heart rate, electrodermal activity, respiratory rate) in response to key 
procedure elements (e.g., needle insertion). Further, bivariate correlations indicated that 
individual differences in self-reported blood and needle fear collected prior to the illusion 
paradigm were significantly associated with presyncopal symptoms reported following the 
procedure. In regression analyses, self-reported measures of blood and needle fear explained 
unique variance in presyncopal symptoms even after controlling for general state anxiety. These 
findings provide initial support for the virtual blood draw paradigm as a promising tool to help 
provide graded exposure to medical procedures involving needles and blood draw.  
 
Keywords: Fear of blood, fear of needles, arm illusion, virtual blood draw, syncope  
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1. Introduction 
Needles and blood draws are used in a variety of medical procedures. In this context, fear 
of blood and needles represents an important individual and public health concern as it is a 
documented deterrent to procedures such as routine blood work [22,38], insulin injections and 
finger sticks for diabetes management [13,39], dental care [7,25], vaccinations [21,32,38], and 
blood donation [38]. A severe form of this fear – termed blood-injection-injury phobia – is 
characterized by an intense fear of blood, injections, medical care, and injury; such fear is 
recognized as excessive and unreasonable by the individual [1]. Blood-injection-injury phobia 
affects approximately 4% of people in the U.S. However, up to a quarter of the adult population 
acknowledges experiencing some fear of needles/blood draws [31,32,38]. 
A unique concern associated with fear of blood or needle stimuli (in comparison to other 
phobias) is that an individual endorsing such fear may be at increased risk for syncopal 
symptoms (e.g., dizziness, lightheadedness) or syncope (i.e., transient loss of consciousness) 
following exposure to blood or needles [10,26,38]. The pre/syncopal response is not universal 
but affects approximately 80% of individuals endorsing such phobia [28,35]. While the 
experience of syncopal symptoms is itself considered medically benign, two risks are of note. 
First, there is an increased risk for physical injury due to falling. Further, the individual may find 
the symptoms distressing, thus promoting avoidance of future medical or otherwise important 
procedures [11,12,29]. 
Considerable evidence suggests that in-vivo exposure is among the most effective 
interventions for blood-injection-injury phobia, as well as variety of other feared experiences or 
stimuli [4,23,24,37]. During in-vivo exposure an individual is asked to come into contact with 
the feared stimulus, usually progressing from the least to most anxiety-provoking aspect of the 
stimulus [4]. Despite success of established exposure protocols, major limitations include the 
need for skilled clinicians, a clinical environment, and significant expenditure of cost and time. 
Accordingly, there is need for relatively inexpensive, accessible, and innovative approaches to 
deliver exposure to feared stimuli associated with a variety of needle and blood-related 
procedures.  
Recent research has begun to examine the potential utility of body illusions to facilitate 
exposure paradigms, which may address limitations of conventional treatments [19,30]. For 
example, the “rubber arm illusion”, first introduced by Botvinick and Cohen in 1998 [3], pairs 
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tactile stimuli to one’s actual arm with that observed on a rubber arm to induce a sense of 
“ownership” of the rubber arm. Drawing on recent research regarding optimal arm illusion 
parameters [3,5,20,34,36], the present study examined an extension of this approach by testing 
simulated ownership of a human arm depicted in virtual/digital format to facilitate exposure to a 
simulated blood draw. The blood draw procedure was selected due to its relevance to both blood 
and needles stimuli as well as syncopal response. As such, we sought to establish a foundation 
for clinical application that could be adapted across various procedures that utilize blood and 
needle stimuli. Accordingly, the purpose of this preliminary study was to examine the feasibility 
of a virtual blood draw to generate a realistic subjective experience. Specifically, we examined 
(1) whether illusion of ownership was successfully induced, (2) the association between self-
report measures relevant to blood and needles and presyncopal reactions in response the virtual 
blood draw, and (3) physiological responses over the course of exposure to the virtual blood 
draw protocol.  
 
2. Materials Methods 
2.1 Participants  
Seventy-four undergraduate students participated in this study. Inclusion criteria included 
(a) age 18 or older, (b) having not donated blood more than once previously, and (c) no self-
reported chronic medical conditions that might contraindicate participation in a potentially 
stressful exposure paradigm (e.g., cardiovascular disease). Potential participants were screened 
by phone for study inclusion. Participants were recruited from a Psychology Department 
research participation pool and received compensation in the form of course credit. All 
participants completed the entire study. All procedures were approved by the University of North 
Texas Institutional Review Board. 
 
2.2 Self-Report Measures 
2.2.1 State-Trait Anxiety Inventory: State Items (STAI-State; [16]). Participant state 
anxiety was assessed through administration of STAI state items. The STAI-State contains 20 
items in which respondents rate their agreement with statements conveying situational anxiety 
(“I feel nervous”; “I am tense”) on a 4-point Likert scale (1=not at all; 4=very much so).  Total 
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scores are obtained for the subscale by summing the 20 items. Higher scores indicate greater 
state anxiety. Internal consistency (Cronbach’s α) for the current sample was α = 0.91. 
2.2.2 Blood Donation Fears Inventory (BDFI; [18]). The BDFI is an 18-item survey that 
assesses individuals’ self-reported fear of blood donation across 4 domains (subscales) – 
syncopal symptoms (9 items), blood and needles (3 items), social evaluation (4 items), and 
health screen results (2 items). Each item is rated on a 5-point Likert scale (1=not at all afraid or 
anxious; 5=extremely afraid or anxious). Subscale scores are totaled and divided by the number 
of items on each subscale to generate an overall score. Higher scores indicate greater fear in each 
domain. Internal consistency for the total BDFI score in the current sample was α = 0.92. Internal 
consistency scores for the subscales were as follows: syncopal symptoms (α = .96), blood and 
needles (α = .92), social evaluation (α = .78), and health screen results (α = .91). 
2.2.3 The Fear of Injections and Blood Draws and Fear of Blood subscales of the 
Medical Fears Survey – Short Version (MFS-SV; [27]). The Fear of Injections and Blood Draws 
(4 items) and Fear of Blood (5 items) subscales of the MFS-SV allow respondents to indicate the 
extent to which they experience fear of medically-related situations such receiving injections and 
giving blood, respectively. These subscales have been shown to predict vasovagal reactions to 
blood donation [27]. Each item is rated on a five-point scale (0=no fear at all; 4=terror).  For the 
current sample, internal consistency scores were α = .87 for the Fear of Injections and Blood 
Draws subscale and α = .85 for the Fear of Blood subscale.  
 2.2.4 Blood Donation Reactions Inventory (BDRI; [9]). Upon completion of the virtual 
arm protocol (described below), participants completed the 4-item BDRI. The BDRI assesses 
subjective physiologic reactions to blood donation associated with vasovagal syncope, including 
faintness, dizziness, weakness, and lightheadedness. Participants indicate the extent to which 
they experienced each of these symptoms on a 6-point Likert-type scale (0=not at all; 
5=extremely); items are summed to provide a total reactions score. Total BDRI scores have a 
high level of internal consistency, positively correlate with phlebotomist ratings of vasovagal 
syncope reactions among blood donors, and predict likelihood of future donations [9]. Internal 
consistency for the current sample was α = .90. 
2.2.5 Manipulation Check. Following the virtual arm protocol, participants were asked 
two questions to assess the extent to which the virtual arm illusion was experienced as realistic.  
Specifically, participants were asked to respond to the statements “I felt the touch of the brush on 
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the digital arm” and “I felt as if the digital arm was my arm” using a 10-point scale ranging from 
0 (do not agree at all) to 9 (agree completely). These questions were adapted from earlier studies 
examining a standard rubber arm illusion [3,14,17] and were administered to capture the key 
perceptual components of the virtual arm protocol.  
 
2.3 Physiological Measures 
2.3.1 Blood Pressure and Heart Rate. Measures of Systolic Blood Pressure (SBP, in 
mmHg), Diastolic Blood Pressure (DBP, in mmHg), and heart rate (HR, in beats per minute) 
were obtained using a Dinamap® V100 Digital Blood Pressure monitor. Appropriately-sized 
blood pressure cuffs were secured to participants’ upper left arm and inflated at key phases of the 
protocol.  
2.3.2 Electrodermal Activity. Continuous monitoring of Electrodermal Activity (EDA, in 
micromhos) was collected using a BIOPAC® MP150 data acquisition system connected to an 
EDA100C amplifier with two LEAD100 electrodes taped to the middle phalanges of the 
participants’ middle and index fingers. AcqKnowledge®, Version 4 software was used to process 
the EDA signal and calculate mean levels (in micromhos/minute).  
2.3.3 Respiration. Continuous monitoring of respiration rate was collected using a 
BIOPAC® MP150 data acquisition system connected to an RSP100C respiration amplifier with a 
TSD201 respiratory effort transducer positioned around the participants’ upper chest. 
AcqKnowledge®, Version 4 software was used to process the respiratory signal and calculate 
respiration rate (in breaths/minute).   
 
2.4 Procedure 
Upon arrival to the laboratory, participants provided consent and completed surveys of 
demographic information, as well as the STAI-State, BDFI, and MFS-SV Fear of Injections and 
Blood Draws and Fear of Blood subscales. Participants were then seated, asked to remove any 
hand jewelry, and asked to position their right arm behind a video monitor (see Figure 1). The 
video monitor was positioned on a rolling desk and obstructed participants’ view of their actual 
arm. Participants were then fitted with physiological equipment. The following instructions were 
then provided: “You will be watching a video of blood being drawn from an arm displayed on 
the screen. We will be attempting to create the illusion that this arm is your own arm. While you 
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will feel sensations similar to those being shown on the video, at no point will a needle be used 
on your arm, and at no point will blood actually be drawn”. Next, participants were instructed to 
remain seated and refrain from speaking during a 5-minute resting baseline assessment of 
physiological measures. Following the baseline period, the experimenter initiated the virtual arm 
illusion.  
2.4.1 Induction of Virtual Arm Illusion and Blood Draw. All footage of human arms and 
blood draws used in this study was previously obtained with consent from six volunteers. 
Footage of three male and three female arms was collected; each arm in each gender category 
represented a gradation in skin tone. To maximize the realism of the arm illusion, participants 
were matched to videos based on gender and skin tone. Each video displayed the arm resting, 
palm up, against a neutral white surface. Footage of the arm began at approximately five inches 
proximal of the antecubital fossa (See Figure 2 for still images of virtual arm stimuli).  
The illusion of the virtual arm ownership was then induced by integrating visual and 
tactile stimuli. The virtual (digital) arm appeared in isolation for approximately 2 seconds. 
Following this, a soft bristle brush was shown repeatedly brushing along the length of the virtual 
arm (from the elbow to the palmar surface of the hand). In synchrony with the video depiction, 
the investigator used an identical brush to provide tactile stimuli to the participant’s arm 
positioned behind the monitor (out of sight of the participant; see Figure 1 and Figure 2A). This 
phase of the protocol lasted approximately 30 seconds and was drawn from prior studies used to 
generate illusions of rubber arm ownership (e.g., [3]). To maintain consistency between real-
world and digital stimuli, the experimenter wore the same white lab coat and gloves as shown in 
the video. 
Next, the video showed a needle and blood flow valve being placed near to the digital 
arm for 30 seconds (see Figure 2B). The digital arm was then depicted being swabbed with 
alcohol while the experimenter simultaneously swabbed the participant’s arm (10 seconds, see 
Figure 2C). The needle was then inserted into the arm on the video (see Figure 2D) while the 
experimenter simultaneously pressed a blunted metal instrument (screwdriver) at the same 
location on the participant’s arm. For the following 60 seconds, participants observed blood 
being drawn from the digital arm (see Figure 2E). Including intervals between actions (e.g., end 
of alcohol swab and needle insertion), the entire protocol, including the 5-minute baseline 
assessment, had a combined duration of approximately 7.2 - 7.5 minutes. 
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Following completion of the virtual arm protocol, participants completed the 
manipulation check questions and the BDRI.  
2.4.2 Phases of the Protocol Corresponding to Physiological Measures. Collection of 
physiological measures began at the beginning of the 5-minute resting baseline assessment. Key 
phases of the protocol were subsequently defined as (a) end of 5-minute resting baseline period –
300-seconds after start of physiological data collection, (b) end of needle insertion – at 370-
seconds, and (c) end of digital blood draw – at 430-seconds (combined duration varied slightly, 
see above). EDA and respiration measures were averaged across phases of the protocol while a 
single reading of BP and HR was initiated at the end of each of these phases.  
 
3. Statistical Approach 
All analyses were conducted using SPSS Version 22.0. Means, standard deviations, and 
counts were calculated for relevant study variables. Male and female participants were compared 
on all self-report measures. As self-report questionnaire data were positively skewed, bivariate 
Spearman correlations were conducted on self-report measures. Subsequently, separate 
hierarchical linear regression analyses were used to examine the unique/incremental contribution 
of measures indicating fear of blood and needle stimuli (scores on the BDFI and subscales, and 
MFS-SV subscales) to participants’ self-reported presyncopal symptoms (BDRI) over and above 
general anxiety (STAI-State), entered into the second block of the regression; potentially 
relevant demographic variables (gender, age, race, BMI) were entered into the first block. All 
questionnaire data were log transformed prior to analysis. Finally, 3-Time repeated measures 
analyses of covariance (RM-ANCOVAs) examined potential changes in physiological measures 
over key phases of the digital arm protocol (end of baseline period, needle insertion, end of 
observed blood draw). For each physiological measure, relevant self-report measures (i.e., STAI-
State, BDFI total and subscales, MFS-SV subscales) were entered as covariates to explore 
potential interaction effects. Degrees of freedom vary slightly due to missing/unobtained data 
across study measures. Effect sizes are reported corresponding to Cohen’s f2 (.02 = small; .15 = 
medium; and .35 = large effect [6]). 
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4. Results 
4.1 Sample Characteristics 
Table 1 provides a summary of participant characteristics for relevant demographic and 
self-report measures, presented for the full sample and separately for men and women. In 
comparison to male participants, women scored significantly higher on the MFS-SV Fear of 
Injections and Blood Draws subscale, F(1,72) = 4.45, p = .04. Women also scored higher on the 
BDFI fear of health screen results subscale, F(1,72) = 4.19, p = .04. No other gender differences 
were observed. 
4.2 Manipulation Check 
 On average, participant responses to manipulation check items reflected successful 
induction of arm ownership (see Table 1 for means and standard deviations). Examination of 
responses to manipulation check items revealed that, of 74 participants, 70 endorsed agreement 
with the statement “I felt the touch of the brush on the digital arm” (i.e., 6 or above on a 0 – 9 
scale). Sixty participants endorsed agreement with the statement “I felt as if the digital arm was 
my arm” (i.e., 6 or above on a 0 – 9 scale). The response rate is concordant with previous 
research [2,15]. Induction of digital arm ownership was thus determined to be successful. 
4.3 Bivariate Correlations  
 Table 2 shows bivariate Spearman correlations among self-report study variables. 
Significant positive associations were observed among all psychosocial measures. Likewise, the 
two manipulation check items were significantly correlated. Of particular interest to the current 
study, BDFI total and subscales scores collected prior to the virtual blood draw manipulation 
showed significant positive correlations with BDRI scores following exposure to the virtual 
blood draw. Similarly, MFS-SV subscale scores were significantly positively correlated with 
BDRI scores. Further, higher endorsement of digital arm ownership (in response to the 
manipulation check item, “I felt as if the digital arm was my arm”) was also significantly 
positively associated with BDRI scores.  
 
4.4 Regression Analyses 
  Table 3 shows the final model for each predictor variable. Of demographic variables 
entered in step 1 of the model, only BMI made a significant contribution to explaining variance 
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in BDRI responses (F∆ = 3.69, p < .01), with the block accounting for 18% of the variance in 
BDRI scores. When added to the model in step 2, the general measure of state anxiety (i.e., 
STAI-State scores) explained an additional 13% of the variance in BDRI responses (F∆ = 13.15, 
p =.001). Finally, seven individual models were examined by completing step 3 using one of 
seven specific fear-related measures. As can be seen in Table 3, total BDFI and each of its 
subscales explained significant additional variance in BDRI scores over and above that explained 
by demographic variables and general state anxiety. This was also the case for MFS-SV-Fear of 
Injections and Blood Draws and MFS-SV-Fear of Blood scores, which accounted for 6% and 5% 
of the variance in BDRI responses, respectively. 
 
4.5 Physiological Outcomes 
Figure 3a-e shows changes in physiological measures across key phases of the study 
protocol (see 2.4.2 Phases of the Protocol Corresponding to Physiological Measures). SBP, 
DBP, and respiration all showed significant elevation from the end of the baseline period to the 
end of needle insertion; F(1,71) = 44.38, p < .001, f2 = .62 (Figure 3a), F(1,71)  = 31.49, p < 
.001, f2 = .44 (Figure 3b), and F(1,71)  = 20.53, p < .001, f2 = .28 (Figure 3c), respectively. A 
significant decline in heart rate was observed between the end of the baseline period and end of 
needle insertion (F(1,73)  =13.73, p < .001, f2 = .19; Figure 3d). Finally, a significant elevation 
in EDA was observed between the end of the baseline period and end of needle insertion 
(F(1,73)  = 106.28, p < .001, f2 = 1.46) as well as between the end of needle insertion and end of 
digital blood draw (F(1,73)  = 97.72, p < .001, f2 = 1.35; Figure 3e). No significant interactions 
were observed with self-report measures. 
 
5. Discussion 
This study sought to examine the feasibility of a virtual blood draw to provide a realistic 
blood draw experience. We examined whether virtual arm ownership could be induced using 
novel methodology, the association between measures relevant to blood draws and report of 
presyncopal symptoms following the virtual blood draw, as well as physiological responses 
during the virtual blood draw protocol. As a primary aim of the current study, responses to the 
manipulation check revealed that the virtual arm illusion was indeed successfully induced in the 
majority of participants. This finding is in agreement with research that points to the robust 
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nature of the rubber arm phenomenon [2,15]. However, to our knowledge this study is the first to 
utilize a virtual platform to generate the rubber arm illusion in order to simulate a blood draw 
experience.  
Significant bivariate associations between scores on the BDFI and MFS-SV subscales 
and BDRI responses following the protocol suggest that the virtual blood draw paradigm elicited 
greater presyncopal symptoms among individuals reporting more fear of the blood draw process. 
This finding provides initial support for the ability of the virtual paradigm to elicit reactions that 
are often observed during an actual blood draw, particularly among those with high levels of 
fear. Validity of the virtual blood draw paradigm is further supported by findings that scores on 
the BDFI, the MFS-SV-Fear of Injections and Blood Draws subscale, and the MFS-SV-Fear of 
Blood subscale explained unique variance in reported presyncopal symptoms beyond general 
state anxiety. Similarly, the positive association between perception of digital arm ownership and 
BDRI responses provides indirect evidence for the utility of this virtual platform; this finding 
suggests a potential role for enhancing realistic perceptual experience in development of such 
methodologies and possible moderation by individual difference factors such as immersability, 
which have been shown to affect interaction with virtual interfaces [e.g., 33] .  
The pattern of physiological activity observed over the course of the protocol provides 
further support for the validity of the virtual blood draw. Specifically, we observed significant 
elevation across four physiological indices (SBP, DBP, respiration, and EDA) from the end of 
the baseline monitoring period to the end of the virtual needle insertion. Interestingly, these 
increases were accompanied by a significant decrease in heart rate from baseline to the end of 
needle insertion, and a significant inverse correlation between systolic blood pressure and heart 
rate changes (r = -0.30, p < .05). This pattern of results suggests a potential carotid baroreflex-
mediated heart rate deceleration in response to initial blood pressure increases. On the whole, 
this pattern of elevated physiologic activity may reflect participants’ increased anxiety in 
anticipation of the needle insertion. Anxious physiological reactions in response to perceived 
threat to a rubber arm have previously been observed [8,15] and interpreted to support the 
realistic nature of the illusion. 
Given the association between BDFI and MFS-SV subscales and presyncopal symptoms, 
it is surprising that no interactions were observed between these self-report measures and 
physiological indices. However, given the nature of the current study, one plausible explanation 
Virtual Blood Draw 12 
 
is that it did not attract participants who were highly fearful of needles or blood draws (see 
Future Directions below). Thus, it is possible that differential physiological responses 
corresponding to self-report measures would become more apparent in a sample with higher 
levels of fear. 
Although the current results require replication, they support the virtual blood draw 
paradigm as a promising tool to help address anxiety related to blood- and needle-related 
procedures. As noted, fear of needles and blood draws is highly disruptive across a number of 
medical and nonmedical contexts (e.g., blood donation, blood testing, vaccinations, etc. [18,38]). 
The virtual platform can be adapted to provide a portable, safe, and flexible analog to practice 
systematic exposure, desensitization to feared stimuli, or coping skills relevant for blood/needle 
procedures [37]. Given its ability to induce presyncopal symptoms among fearful participants, 
the paradigm can provide a context to target such symptoms directly using interventions such as 
applied muscle tension [23]. The virtual protocol could also be used to simulate exposure to 
blood donation for individuals who have not previously donated blood or experienced a specific 
medical procedure. Further, any presyncopal reactions identified in the virtual context may then 
be addressed prior to actual blood draw.  
5.1 Limitations and Future Directions. 
The goal of the virtual blood draw paradigm is ultimately to promote reduced fear to 
blood draw stimuli; however, actual fear or avoidance behavior in response to real world stimuli 
was not assessed in the current study – interventions and contexts of a more realistic nature 
should be addressed in future research. In line with this, assessment of the feasibility and 
ultimate clinical utility of this approach will require testing in target populations, in particular, 
individuals with BII phobia, who may differ in psychological and physiological responses from 
nonclinical counterparts. In addition, although this initial validation was conducted in healthy 
participants, many chronic medical conditions require management using needle procedures 
(e.g., diabetes) and should be targeted by future research. It is also worth noting that the present 
study tested a very specific form of blood and needle procedure (i.e., having blood drawn from 
the arm) more suited for certain contexts, such as blood draw for medical testing and blood 
donation. Given the flexibility of the virtual paradigm, future studies may wish to examine 
virtual exposure to a broader range of blood- and needle-relevant scenarios.  
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In general, given the early nature of body-illusion studies in reference to blood draws and 
fear of blood draw stimuli, additional research is needed to determine which factors (e.g., visual 
input, perceived arm ownership, haptic perception) are crucial to the proposed approach; for 
instance, a natural extension of the current study is comparison of the current protocol (which 
pairs blood draw footage with induction of arm ownership) with observation of blood draw 
footage only. As this was the first adaptation of the arm illusion paradigm to a blood/needle 
procedure, future studies may wish to more specifically assess perceptual experiences related to 
these stimuli (e.g., the experience needle insertion) as well as psychosocial moderators such as 
social desirability and immersability. Finally, further research is need to determine what types of 
virtual interfaces (e.g., fully immersive, audiovisual, haptic) are most compatible with blood 
draw/needle simulations and with promoting associated health-relevant behaviors.  
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Table 1.  Characteristics of the participant sample. 
  Full Sample (n = 74)  Women (n = 51)   Men (n = 23) 
Variable (Units)  n Range Mean SD  n Range Mean (SD)  n Range Mean (SD) 
Dominant Hand†                
Right  68 - - -  47 - - -  21 - - - 
Left  4 - - -  2 - - -  2 - - - 
Race                
White  43 - - -  30 - - -  13 - - - 
Black  12 - - -  9 - - -  3 - - - 
Asian  4 - - -  3 - - -  1 - - - 
Other  15 - - -  9 - - -  6 - - - 
Age (years)   18-29 20.2 2.4  - 18-26 10.0 2.0   - 18-29 21.1 3.0 
BMI (kg/m2)  - 19.2 – 41.2 25.3 4.6  - 19.2 – 41.2 25.2 5.0  - 20.2 – 35.0 25.6 3.7 
STAI-State  - 20.00 – 61.00 34.1 9.5  - 20.0 – 61.0 35.4 9.7  - 20.0 – 51.0 31.5 8.3 
BDFI   -          -    
Total  - 0 – 13.8 5.3 3.8  -  0 – 13.8 5.8 4.1  - 0 – 9.9 4.3 2.7 
Syncopal  - 0 – 36.0 11.4 8.7  - 0 – 36.0 12.2 9.0  - 0 – 26.0 9.6 8.0 
Blood-Needles  - 0 – 12.0 3.6 3.1  - 0 – 12.0 3.8 3.9  - 0 – 8.0 3.1 2.6 
Social Eval.  - 0– 15.0 5.7 3.8  - 0 – 15.0 6.0 4.2  - 0 – 11.0 4.5 2.9 
Health Screen*  - 0 – 8.0 2.8 2.6  - 0 – 8.0 3.3 3.3  - 0 – 5.0 1.9 1.7 
MFS-SV                  -    
Injections*  - 0 – 13.0 3.6 3.2  - 0 – 13.0  4.1 3.5  - 0 – 8.00 2.8 2.1 
Blood  - 0 – 14.0 1.5 2.6  - 0 – 14.0  1.6 2.8  - 0 – 8.0 1.4 2.1 
BDRI  - 0 – 13.0 1.9 3.0  - 0 – 13.0  1.8 2.8  - 0 – 13.0 2.0 3.4 
Manip. Check                
Felt brush  - 0 – 9 8.0 2.3  - 0 – 9 8.4 2.0  - 0 – 9 7.9 2.0 
Felt my arm  - 1 – 9 7.2 2.0  - 2 – 9 7.4 1.7  - 1 – 9 7.3 2.1 
*p < .05 denotes difference between genders; †Denotes sample size varies due to missing/unobtained data; BMI = Body Mass Index; BDFI = Blood Donation Fears Inventory; 
BDFI Syncopal = fear of syncopal symptoms; STAI-State = State-Trait Anxiety Inventory – State items; BDFI Blood-Needles = fear of blood and needles; BDFI Social Eval. = 
fear of social evaluation; BDFI Health Screen = fear of health screen results; MFS-SV = Medical Fears Survey-Short Version; MFS-SV Injections = Fear of Injections and 
Blood Draws; MFS-SV Blood = Fear of Blood; BDRI = Blood Donation Reactions Inventory; Manip. Check = Manipulation Check: Felt brush = response to “I felt the touch of 
the brush on the digital arm”; Manipulation Check: Felt my arm = response to “I felt as if the digital arm was my arm”. 
 
  
Table 2.  Spearman correlation among study variables. 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 
1. Age (years)             
2. BMI .19            
3. STAI-State -.19  -.15           
4. BDFI Total -.06 -.41** .29*          
5. BDFI Syncopal -.07 -.37** .26* .90**         
6. BDFI Blood-Needles -.16 -.42** .23* .85** .83**        
7. BDFI Social Eval. -.10 -.30** .24* .84** .67** .63**       
8. BDFI Health Screen .10 -.28* .31** .84** .63** .55** .73**      
9. MFS-SV Injection .15 -.36** .23* .74** .56** .50** .60** .82**     
10. MFS-SV Blood .06 -.33** .18 .56** .54** .50** .41** .44** .48**    
11. BDRI .06 -.38** .35** .61** .60** .52** .45** .54** .44** .37**   
12. Manip - Felt brush -.23 -.31** .16 .10 .06 .14 .10 .13 .09 -.06 .13  
13. Manip - Felt my arm -.18  -.12 .18 .24* .23* .26* .21 .20 .25* .11 .31** .51** 
*p < .05, **p < .01; BMI = Body Mass Index; STAI-State = State-Trait Anxiety Inventory – State items; BDFI = Blood Donation Fears 
Inventory; BDFI Syncopal = fear of syncopal symptoms; BDFI Blood-Needles = fear of blood and needles; BDFI Social Eval. = fear of social 
evaluation; BDFI Health Screen = fear of health screen results; MFS-SV = Medical Fears Survey-Short Version; MFS-SV Injections = Fear 
of Injections and Blood Draws; MFS-SV Blood = Fear of Blood; BDRI = Blood Donation Reactions Inventory; Manip - Felt brush = response 
to manipulation check item “I felt the touch of the brush on the digital arm”; Manip - Felt my arm = response to manipulation check item “I 
felt as if the digital arm was my arm”. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 3. Regression analyses for Blood Donation Reactions Inventory scores  
 R2 change      F     β        t f2 
Step 1 
Age (years) 
Gender (male = 1) 
Body Mass Index (kg/m2) 
Race (White = 2; Non-White = 1) 
Step 2 
STAI-State 
Step 3a 
       Model 1. BDFI Total 
       Model 2. BDFI Syncopal 
       Model 3. BDFI Blood-Needles 
       Model 4. BDFI Social Eval 
       Model 5. BDFI Health Screen 
       Model 6. MFS-SV Injection 
Model 7. MFS-SV Blood 
.18 
 
 
 
 
 
.13 
 
.14 
.12 
.14 
.07 
.11 
.05 
.06 
3.70** 
 
 
 
 
 
6.11** 
 
9.09** 
8.40** 
9.00** 
6.89** 
7.95** 
6.35** 
6.44** 
 
.12 
-.02 
-.39 
-.11 
 
.38 
 
.44 
.39 
.42 
.30 
.37 
.27 
.25 
 
1.05 
-.15 
-3.56** 
-.94 
 
3.63** 
 
4.11** 
3.74** 
4.06** 
2.78** 
3.49** 
2.35* 
2.43* 
21 
 
 
 
 
 
.15 
 
.16 
.14 
.16 
.08 
.12 
.05 
.06 
*p < .05, **p < .01, All self-report questionnaire data were log transformed prior to analysis; results did not differ 
substantially between transformed and non-transformed data. a For the third step in the regression, results are presented 
for separate models if the specific fear variable was entered. STAI-State = State Trait Anxiety Inventory – State items; 
BDFI = Blood Donation Fears Inventory; BDFI Syncopal = fear of syncopal symptoms; BDFI Blood-Needles = fear of 
blood and needles; BDFI Social Eval. = fear of social evaluation; BDFI Health Screen = fear of health screen results; 
MFS = Medical Fears Survey-Short Version; MFS - SV Injections = Fear of Injections and Blood Draws; MFS-SV Blood 
= Fear of Blood 
 
 
 
 
 
 
 
 
 
 
Figure 1. Participant undergoing virtual arm protocol.  
 
 
 
  
 
 
 
 
 Figure 2. Overview of virtual arm protocol. 
 
 
   
A. Induction of digital arm ownership. 
D. Needle insertion.  E. Blood draw.  
B. Needle stimuli in proximity to arm. C. Alcohol swab. 
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Figure 3a - e. Key phases of the protocol: (a) end of 5-
minute resting baseline period (b) end of needle 
insertion, and (c) end of digital blood draw. *Indicates 
significant change.  
* *
*
*
*
*
Figure 3a.  Figure 3b.
Figure 3c.  Figure 3d. 
Figure 3e. 
